PriceTargets.com logo

Ra Medical Systems - RMED Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 08/17/2023 09:00 PM ET
+0 (0.00%)
Get New Ra Medical Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RMED and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RMED

Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for Ra Medical Systems in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.

This chart shows the closing price for RMED for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Ra Medical Systems. This rating has held steady since February 2023, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/3/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/30/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/29/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/28/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/24/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/18/2022HC WainwrightReiterated RatingBuy$600.00
10/21/2021HC WainwrightInitiated CoverageBuy$600.00
3/23/2021Maxim GroupReiterated RatingBuy ➝ Hold
3/17/2021Maxim GroupDowngradeBuy ➝ Hold
11/29/2020Piper SandlerLower TargetNeutral$600.00 ➝ $350.00
7/31/2020Piper SandlerLower TargetNeutral$1,250.00
6/12/2020Maxim GroupReiterated RatingBuy$2,500.00
5/15/2020Maxim GroupReiterated RatingBuy$3,750.00
5/14/2020Piper SandlerLower TargetNeutral$1,875.00 ➝ $1,250.00
3/12/2020Maxim GroupReiterated RatingBuy
3/11/2020Cantor FitzgeraldLower TargetNeutral$2,500.00 ➝ $1,875.00
(Data available from 1/24/2020 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/28/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/28/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/26/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/26/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/24/2025

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Ra Medical Systems logo
Ra Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.73
Low: $0.54
High: $1.10

52 Week Range

Now: N/A

Volume

77,500 shs

Average Volume

197,480 shs

Market Capitalization

$3.19 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Ra Medical Systems?

The following equities research analysts have issued stock ratings on Ra Medical Systems in the last year:
View the latest analyst ratings for RMED.

What is the current price target for Ra Medical Systems?

0 Wall Street analysts have set twelve-month price targets for Ra Medical Systems in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Ra Medical Systems in the next year.
View the latest price targets for RMED.

What is the current consensus analyst rating for Ra Medical Systems?

Ra Medical Systems currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for RMED.

What other companies compete with Ra Medical Systems?

Other companies that are similar to Ra Medical Systems include Lyra Therapeutics, STRATA Skin Sciences, Adagio Medical, Carmell and Aethlon Medical. Learn More about companies similar to Ra Medical Systems.

How do I contact Ra Medical Systems' investor relations team?

Ra Medical Systems' physical mailing address is 2070 Las Palmas Drive, Carlsbad CA, 92011. The company's listed phone number is (973) 691-2000 and its investor relations email address is [email protected]. The official website for Ra Medical Systems is www.ramed.com. Learn More about contacing Ra Medical Systems investor relations.